How will I know if my Endometrial Cancer treatment is working

Endometrial CancerMay 20, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

How to Know If Your Endometrial Cancer Treatment Is Working

This is one of the most important questions you can ask during your cancer journey. Let me explain the different ways your medical team monitors treatment response and what you should be tracking.

Standard Monitoring Approaches

Imaging Scans Your oncologist will typically use CT scans, MRI, or PET scans at regular intervals (often every 3 months) to visualize your tumors and see if they're shrinking, staying stable, or growing. These scans measure the physical size of tumors, which is the traditional way doctors assess treatment effectiveness.

However, there's an important limitation: imaging can only reliably detect tumors that are about 1 centimeter (roughly the size of a pea) or larger. This means very small disease may not show up on scans, and conversely, you might see changes on imaging before you feel any physical symptoms.

Blood Tests and Tumor Markers Your doctor may monitor:

CA-125: A protein marker that can be elevated in endometrial cancer. Rising levels may suggest progression, while falling levels suggest response
General blood work: Hemoglobin, white blood cell counts, liver and kidney function to ensure treatment isn't causing harmful side effects

Physical Symptoms and Quality of Life Pay attention to:

Vaginal bleeding or discharge changes
Pelvic pain or pressure
Energy levels and ability to do daily activities
Side effects from treatment (fatigue, nausea, etc.)

The Three-Month Evaluation Cycle

According to the webinar "Molecular Integrative Oncology: In Addition to – Not instead of – Conventional Oncology Treatment" by Dr. [removed] LaValley, oncologists typically use a structured approach: every three months, your team performs imaging or other evaluations, then decides whether to continue current treatment, modify it, or make a change. This regular rhythm helps catch changes early and adjust your plan as needed.

Emerging Monitoring Tools (Beyond Standard Imaging)

Liquid Biopsies (Blood Tests for Cancer DNA) As discussed in the "Liquid Biopsies" webinar by Peter Kuhn and Stephanie Shishido, liquid biopsies measure circulating tumor DNA (ctDNA) — fragments of cancer DNA floating in your bloodstream. This approach offers several advantages:

Earlier detection: Can potentially identify disease changes before imaging shows them
Non-invasive: Simple blood draw instead of imaging
Repeated monitoring: Can be done more frequently without radiation exposure
Real-time feedback: Provides information about whether your treatment is actually working at the cellular level

The key insight from the webinar is important: "Just because I can detect something does not mean I can improve the outcome." Detecting disease earlier only helps if you have effective treatment options available. Your doctor will help determine if earlier detection through liquid biopsy changes your treatment decisions.

Functional Testing (Testing Drugs on Your Tumor) The webinar "Finding Personalized Cancer Treatments Beyond the Standard through a Unique Test" by Travera describes an emerging approach: taking fresh tumor tissue and testing multiple drugs directly on your cancer cells in the laboratory. This can show which drugs are actually working against YOUR specific cancer before you start them. The predictive accuracy of this approach is approximately 85%, meaning it correctly predicts treatment response about 85% of the time.

For gynecological cancers like endometrial cancer, this testing is particularly relevant if you're having surgery or a biopsy, as fresh tissue can be collected and tested.

What You Should Ask Your Oncologist

To develop a clear monitoring plan, ask:

"What is my baseline?" — What do my scans/blood work look like right now, before treatment starts?
"When will we check if treatment is working?" — What's the schedule for imaging and blood tests?
"What counts as a good response?" — What changes would indicate the treatment is working? (e.g., tumor shrinkage of 30% or more)
"What are the warning signs?" — What findings would mean we need to change treatment?
"Are there additional tests available?" — Ask about liquid biopsies or functional testing if you're interested in more detailed monitoring
"How will we measure quality of life?" — Beyond imaging, how will we track whether treatment is helping you feel better and function better?

Important Perspective

The webinar "Molecular Integrative Oncology" emphasizes that treatment must be well-tolerated to be effective. If side effects are so severe that you can't continue treatment, it can't help you. So part of "treatment working" includes managing side effects so you can actually complete your therapy.